Homepage
Author:
CO-DIAGNOSTICS
Posted Date:
April 9, 2026
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
CO-DIAGNOSTICS
April 9, 2026
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia’s Sudair Industrial City
CO-DIAGNOSTICS
April 2, 2026
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
CO-DIAGNOSTICS
March 25, 2026
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
CO-DIAGNOSTICS
March 20, 2026
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
CO-DIAGNOSTICS
March 17, 2026
Co-Diagnostics to Present at Medical Korea 2026
CO-DIAGNOSTICS
March 16, 2026
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
CO-DIAGNOSTICS
March 12, 2026
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
CO-DIAGNOSTICS
March 10, 2026
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
CO-DIAGNOSTICS
February 12, 2026
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
CO-DIAGNOSTICS
February 8, 2026
1
2
Next
